Edition:
United Kingdom

Affimed NV (AFMD.OQ)

AFMD.OQ on NASDAQ Stock Exchange Global Market

2.85USD
20 Aug 2019
Change (% chg)

$0.02 (+0.71%)
Prev Close
$2.83
Open
$2.85
Day's High
$2.88
Day's Low
$2.77
Volume
119,220
Avg. Vol
233,113
52-wk High
$7.35
52-wk Low
$1.55

About

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body's own immune system to fight tumor cells. Its... (more)

Overall

Beta: 2.79
Market Cap(Mil.): $184.99
Shares Outstanding(Mil.): 62.39
Dividend: --
Yield (%): --

Financials

  AFMD.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.17 -- --
ROI: -13.94 7.52 12.69
ROE: -19.44 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates